Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "global" return 73 results.
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Ceva acquires CentaurVA Animal Health >
Company continues to expand its North American operations with entry into Canada.
Ceva Animal Health growth affirms "together, beyond animal health" initiative >
August 29, 2011, Lenexa, Kan. – Just one year later, a strategic acquisition, plant expansion and a strengthened management team for the two arms of Ceva Animal Health, the U.S. business unit of Ceva...
Ceva's New Poultry Vaccine Production Facility >
Ceva Animal Health (Ceva), a wholly owned US subsidiary of Ceva Santé Animale and a leading player in the global animal health industry, launched a new poultry vaccine production facility in May 2011.
Ceva Offers Veterinarians Guidance on Flea & Tick Category >
AVMA Convention Lunchtime Express Connection: Saturday, July 16, 2011 at noon
Joint venture agreement between Ceva and Huadu signed in Beijing >
"Ceva Huadu" to become innovation and R&D platform for biologicals
Ceva moves to further boost growth in U.S. and Biology segments >
Following strong, rapid growth in 2010, Ceva Santé Animale expands executive team with appointment of Craig Wallace
New appointments follow Ceva’s integration of Summit VetPharm into a single US companion animal business >
Brad Butler appointed Chief Operations Officer; Julia Stephanus appointed Vice President, Global Marketing - Companion Animal Parasiticides
Dr. Steve Chu joins Ceva >
Addition to talented team positions Ceva for continued growth
Hoffman Appointed Ceva Director of Marketing, Companion Animals >
-- Hiring Sets the Stage for Continued Growth --